[CAS NO. 2682114-39-0]  RBPJInhibitor-1

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [2682114-39-0]

Distributor
Catalog
HY-137471
Brand
MCE
CAS
2682114-39-0

DESCRIPTION [2682114-39-0]

Overview

MDL-
Molecular Weight311.31
Molecular FormulaC17H14FN3O2
SMILESO=C(N)C1=CC=C(C2=CC=NN2C)C=C1OC3=CC=CC=C3F

For research use only. We do not sell to patients.

1 Publications Citing Use of MCE


Summary

RBPJ Inhibitor-1 (RIN1), the first RBPJ inhibitor, blocks the functional interaction of RBPJ with SHARP. RBPJ Inhibitor-1 (RIN1) inhibits NOTCH-dependent tumor cell proliferation [1] .


In Vitro

RIN1 inhibits the proliferation of hematologic cancer cell lines and promoted skeletal muscle diferentiation from C2C12 myoblasts [1] .
RIN1 (0.6 µM, corresponding to 3 × IC 50 ) decreases the number of MHC+ cells and increased the number of nuclei per cell, indicating that it induces the formation of multinucleated myofbers [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: AD-293 cells were transfected with RBPJ-VP16myc.
Concentration: 2 μM.
Incubation Time: 17 hours.
Result: Inhibited Hes1-Luciferase activity with an IC 50 of 0.18 µM and E max of 82%.
Inhibited NOTCH3 ICD with similar potency and efcacy (0.19 µM and E max =88%).

Cell Proliferation Assay [1]

Cell Line: T-cell acute lymphoblastic leukemia (T-ALL) patients (Jurkat and KOPT-K1) and in the mantle cell lymphoma (MCL) line REC-1.
Concentration: 0.1-10 μM.
Incubation Time: 96 h.
Result: Inhibited NOTCH-dependent tumor cell proliferation.
Was active in both the cancer cell anti-proliferation and myoblast diferentiation assays.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month

Solvent & Solubility

In Vitro:

DMSO : 250 mg/mL ( 803.06 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.2122 mL 16.0612 mL 32.1223 mL
5 mM 0.6424 mL 3.2122 mL 6.4245 mL
10 mM 0.3212 mL 1.6061 mL 3.2122 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 2.08 mg/mL (6.68 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (6.68 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 2.08 mg/mL (6.68 mM); Clear solution

* All of the co-solvents are available by MCE.